Travere Therapeutics Inc (TVTX)
5.98
+0.45
(+8.14%)
USD |
NASDAQ |
May 01, 16:00
6.08
+0.10
(+1.67%)
Pre-Market: 08:32
Travere Therapeutics Gross Profit Margin (Quarterly): 89.87% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 89.87% |
| September 30, 2023 | 96.53% |
| June 30, 2023 | 96.67% |
| March 31, 2023 | 91.01% |
| December 31, 2022 | 97.04% |
| September 30, 2022 | 96.03% |
| June 30, 2022 | 96.21% |
| March 31, 2022 | 95.59% |
| December 31, 2021 | 97.21% |
| September 30, 2021 | 97.67% |
| June 30, 2021 | 96.98% |
| March 31, 2021 | 96.53% |
| December 31, 2020 | 95.94% |
| September 30, 2020 | 97.68% |
| June 30, 2020 | 96.92% |
| March 31, 2020 | 97.13% |
| December 31, 2019 | 96.31% |
| September 30, 2019 | 96.59% |
| June 30, 2019 | 97.81% |
| March 31, 2019 | 97.43% |
| Date | Value |
|---|---|
| December 31, 2018 | 96.34% |
| September 30, 2018 | 97.22% |
| June 30, 2018 | 97.15% |
| March 31, 2018 | 95.80% |
| December 31, 2017 | 97.22% |
| September 30, 2017 | 97.71% |
| June 30, 2017 | 97.95% |
| March 31, 2017 | 97.89% |
| December 31, 2016 | 96.78% |
| September 30, 2016 | 95.37% |
| June 30, 2016 | 96.93% |
| March 31, 2016 | 97.39% |
| December 31, 2015 | 97.50% |
| September 30, 2015 | 98.17% |
| June 30, 2015 | 97.35% |
| March 31, 2015 | 98.42% |
| December 31, 2014 | 97.60% |
| September 30, 2014 | 97.63% |
| June 30, 2014 | 99.39% |
| March 31, 2014 | 96.77% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
89.87%
Minimum
Dec 2023
97.81%
Maximum
Jun 2019
96.09%
Average
96.59%
Median
Sep 2019
Gross Profit Margin (Quarterly) Benchmarks
| AtriCure Inc | 74.91% |
| Bio-Rad Laboratories Inc | 53.78% |
| Artivion Inc | 65.22% |
| Shockwave Medical Inc | 87.53% |
| Perspective Therapeutics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -67.18% |
| Return on Assets | -14.51% |
| Return on Invested Capital | -20.55% |
| Profit Margin (Quarterly) | -200.1% |
| Operating Margin (Quarterly) | -183.8% |
| Return on Net Operating Assets | -60.52% |